FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2577441330> ?p ?o ?g. }

• W2577441330 endingPage "14548" @default.
• W2577441330 startingPage "14537" @default.
• W2577441330 abstract "// Chien-Yi Chan 1 , Shih-Yi Huang 2 , Jim Jinn-Chyuan Sheu 3, 4 , Mendel M. Roth 5 , I-Tai Chou 1 , Chia-Hsien Lien 1 , Ming-Fen Lee 6, * , Chun-Yin Huang 1, 4, * 1 Department of Nutrition, China Medical University, Taichung, Taiwan 2 School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan 3 Institute of Biomedical Sciences, National Sun Yatsen University, Kaohsiung, Taiwan 4 Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan 5 GB Lifesciences, San Diego, CA, USA 6 Department of Nutrition and Health Sciences, Chang Jung Christian University, Tainan, Taiwan * These authors contributed equally to this work Correspondence to: Chun-Yin Huang, email: chuang@mail.cmu.edu.tw Ming-Fen Lee, email: leemf@mail.cjcu.edu.tw , summerblueair@yahoo.com Keywords: FOXO1, HBP1, oral cancer Received: September 16, 2016      Accepted: January 07, 2017      Published: January 14, 2017 ABSTRACT Either FOXO1 or HBP1 transcription factor is a downstream effector of the PI3K/Akt pathway and associated with tumorigenesis. However, the relationship between FOXO1 and HBP1 in oral cancer remains unclear. Analysis of 30 oral tumor specimens revealed that mean mRNA levels of both FOXO1 and HBP1 in non-invasive and invasive oral tumors were found to be significantly lower than that of the control tissues, and the status of low FOXO1 and HBP1 (< 0.3 fold of the control) was associated with invasiveness of oral tumors. To investigate if HBP1 is a direct transcription target of FOXO1, we searched potential FOXO1 binding sites in the HBP1 promoter using the MAPPER Search Engine, and two putative FOXO1 binding sites located in the HBP1 promoter –132 to –125 bp and –343 to –336 bp were predicted. These binding sites were then confirmed by both reporter gene assays and the in cellulo ChIP assay. In addition, Akt activity manipulated by PI3K inhibitor LY294002 or Akt mutants was shown to negatively affect FOXO1-mediated HBP1 promoter activation and gene expression. Last, the biological significance of the FOXO1-HBP1 axis in oral cancer malignancy was evaluated in cell growth, colony formation, and invasiveness. The results indicated that HBP1 knockdown potently promoted malignant phenotypes of oral cancer and the suppressive effect of FOXO1 on cell growth, colony formation, and invasion was alleviated upon HBP1 knockdown in invasive oral cancer cells. Taken together, our data provide evidence for HBP1 as a direct downstream target of FOXO1 in oral cancer malignancy." @default.
• W2577441330 created "2017-01-26" @default.
• W2577441330 creator A5000983980 @default.
• W2577441330 creator A5015108441 @default.
• W2577441330 creator A5029773231 @default.
• W2577441330 creator A5029808246 @default.
• W2577441330 creator A5037307614 @default.
• W2577441330 creator A5054972944 @default.
• W2577441330 creator A5080349322 @default.
• W2577441330 creator A5086854638 @default.
• W2577441330 date "2017-01-14" @default.
• W2577441330 modified "2023-09-30" @default.
• W2577441330 title "Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer" @default.
• W2577441330 cites W1628841297 @default.
• W2577441330 cites W1973244778 @default.
• W2577441330 cites W1982081546 @default.
• W2577441330 cites W1990790246 @default.
• W2577441330 cites W2001604240 @default.
• W2577441330 cites W2001900537 @default.
• W2577441330 cites W2003779663 @default.
• W2577441330 cites W2006771504 @default.
• W2577441330 cites W2016434015 @default.
• W2577441330 cites W2020777578 @default.
• W2577441330 cites W2035926347 @default.
• W2577441330 cites W2036363901 @default.
• W2577441330 cites W2042682612 @default.
• W2577441330 cites W2058896449 @default.
• W2577441330 cites W2070942270 @default.
• W2577441330 cites W2080020412 @default.
• W2577441330 cites W2087784335 @default.
• W2577441330 cites W2087823564 @default.
• W2577441330 cites W2088442622 @default.
• W2577441330 cites W2091826086 @default.
• W2577441330 cites W2107832538 @default.
• W2577441330 cites W2113002082 @default.
• W2577441330 cites W2115612586 @default.
• W2577441330 cites W2117086969 @default.
• W2577441330 cites W2117660667 @default.
• W2577441330 cites W2122118991 @default.
• W2577441330 cites W2126708302 @default.
• W2577441330 cites W2129039722 @default.
• W2577441330 cites W2137035181 @default.
• W2577441330 cites W2166243731 @default.
• W2577441330 cites W2166353463 @default.
• W2577441330 cites W2167466202 @default.
• W2577441330 cites W2170177166 @default.
• W2577441330 cites W2331113172 @default.
• W2577441330 cites W2388163742 @default.
• W2577441330 cites W46317827 @default.
• W2577441330 doi "https://doi.org/10.18632/oncotarget.14653" @default.
• W2577441330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5362424" @default.
• W2577441330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28099936" @default.
• W2577441330 hasPublicationYear "2017" @default.
• W2577441330 type Work @default.
• W2577441330 sameAs 2577441330 @default.
• W2577441330 citedByCount "11" @default.
• W2577441330 countsByYear W25774413302018 @default.
• W2577441330 countsByYear W25774413302019 @default.
• W2577441330 countsByYear W25774413302020 @default.
• W2577441330 countsByYear W25774413302023 @default.
• W2577441330 crossrefType "journal-article" @default.
• W2577441330 hasAuthorship W2577441330A5000983980 @default.
• W2577441330 hasAuthorship W2577441330A5015108441 @default.
• W2577441330 hasAuthorship W2577441330A5029773231 @default.
• W2577441330 hasAuthorship W2577441330A5029808246 @default.
• W2577441330 hasAuthorship W2577441330A5037307614 @default.
• W2577441330 hasAuthorship W2577441330A5054972944 @default.
• W2577441330 hasAuthorship W2577441330A5080349322 @default.
• W2577441330 hasAuthorship W2577441330A5086854638 @default.
• W2577441330 hasBestOaLocation W25774413301 @default.
• W2577441330 hasConcept C104317684 @default.
• W2577441330 hasConcept C121608353 @default.
• W2577441330 hasConcept C126322002 @default.
• W2577441330 hasConcept C140149449 @default.
• W2577441330 hasConcept C502942594 @default.
• W2577441330 hasConcept C54355233 @default.
• W2577441330 hasConcept C555283112 @default.
• W2577441330 hasConcept C62478195 @default.
• W2577441330 hasConcept C71924100 @default.
• W2577441330 hasConcept C75217442 @default.
• W2577441330 hasConcept C86339819 @default.
• W2577441330 hasConcept C86554907 @default.
• W2577441330 hasConcept C86803240 @default.
• W2577441330 hasConceptScore W2577441330C104317684 @default.
• W2577441330 hasConceptScore W2577441330C121608353 @default.
• W2577441330 hasConceptScore W2577441330C126322002 @default.
• W2577441330 hasConceptScore W2577441330C140149449 @default.
• W2577441330 hasConceptScore W2577441330C502942594 @default.
• W2577441330 hasConceptScore W2577441330C54355233 @default.
• W2577441330 hasConceptScore W2577441330C555283112 @default.
• W2577441330 hasConceptScore W2577441330C62478195 @default.
• W2577441330 hasConceptScore W2577441330C71924100 @default.
• W2577441330 hasConceptScore W2577441330C75217442 @default.
• W2577441330 hasConceptScore W2577441330C86339819 @default.
• W2577441330 hasConceptScore W2577441330C86554907 @default.
• W2577441330 hasConceptScore W2577441330C86803240 @default.
• W2577441330 hasIssue "9" @default.
• W2577441330 hasLocation W25774413301 @default.

• next